Diabeloop
French tech company | Builders Republic
About
Medical-device company that helps people with type 1 diabetes automate insulin treatment — its DBLG1 closed-loop system reads continuous glucose data and self-adjusts an insulin pump in real time using personalized algorithms, interoperable with third-party pumps and sensors, distributed through healthcare channels.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series C
- Founded
- 2015
- City
- GRENOBLE
- Region
- Auvergne-Rhône-Alpes
- Legal name
- DIABELOOP
- SIREN
- 810416438
- Tracked rounds
- 2
- Amount raised
- 85 M€ raised since 2020
Funding rounds
- Series C — 2024
- Series C — 2022
Investors
- Agir A Dom
- Cemag Invest
- Ceritd
- Crédit Agricole
- LBO France
- Odyssée Venture
- Promontoires
- Supernova Invest
- Terumo Corporation
- Turenne Capital
- UI Investissement
Notes
Procédure de sauvegarde (tribunal de commerce de Grenoble). Après la perte d'un partenariat clé en 2022-2023, la société cherche à lever des fonds pour se restructurer (nouveau dirigeant François Miceli, 2024).